Jon Price – Managing Director – Richmond Vanadium Technology (ASX:RVT) is an Australian minerals development company which is advancing the Richmond – Julia Creek Vanadium Project in Queensland through a Bankable Feasibility Study.
Copyright 2023 – Finance News Network
Source: Finance News Network
10 May 2024 - Empire Energy Group's journey toward Beetaloo Basin production and its strategic moves, including asset sales and capital raises, shaping Australia's gas sector landscape.
Read More16 Aug 2023 - Sam Budiselik - Managing Director - Cash Converters (ASX:CCV) is a diverse group generating revenues from franchising, store operations, personal and vehicle finance.
Read More09 Jan 2020 - IVE Group Limited (ASX:IGL) Executive Chairman, Geoff Selig, discusses the company's recent acquisition of Salmat Marketing Solutions and Reach Media New Zealand and its recent move to trading under the one IVE brand.
Read More27 Feb 2024 - QX Resources Limited (ASX:QXR) Managing Director Steve Promnitz discusses iron ore results from the company's assets in the Pilbara.
Read More05 Nov 2021 - BrainChip Holdings Limited (ASX:BRN) Vice President of Worldwide Sales and Marketing Rob Telson talks about the company and the future of artificial intelligence.
Read More27 May 2024 - Jonathan Belz, founder of BFA Global connects Australian and Asian family offices with top global investment opportunities in venture capital, private equity, and technology. He shares insights into the future of alternative assets and investment strategies.
Read More10 Mar 2025 - CEO Marc Voigt on Clinical Trials, Regulatory Milestones, and Market Growth
Read More02 Jun 2023 - Falcon Metals Limited (ASX:FAL) Managing Director Tim Markwell discusses progress with the company's gold exploration, touching on key prospects and the results timeline.
Read More20 Jan 2021 - National Retail Association CEO Dominique Lamb discusses retail performance over the Christmas period, trends in retail, and strategies for encouraging consumer spending.
Read More11 Dec 2024 - INOVIQ's recent validation study of its EXO-OC test revealed it can detect stage one ovarian cancer with 96% specificity and more than 90% sensitivity, a promising advance for early detection.
Read More
